Video

CURE Community Vlog: One Patient's Journey With Merkel Cell Carcinoma

Author(s):

“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”

In just 10 days, Sue began her journey with Merkel cell carcinoma — a rare type of skin cancer that usually appears as a flesh-colored or bluish-red nodule, often on your face, head or neck.

She underwent seven surgeries on the left side of her nostril before receiving chemotherapy and radiation.

“There was so little research at the time,” she recalled.

“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”

Related Videos
Image of woman.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of woman with blonde hair.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Treatment with cemacabtagene ansegedleucel demonstrated responses in patients with relapsed or treatment-resistant large B-cell lymphoma.
There was no evidence that CAR T directly caused secondary malignancies, despite FDA warnings, citing prior treatments as the cause, according to research.
Image of woman with black hair.
Image of man with black hair.